Outlook Therapeutics, Inc. Recorded Big Gain

Tue 03 Dec 19 at 05:30 PM
Outlook Therapeutics, Inc. Recorded Big Gain

Outlook Therapeutics, Inc. (OTLK:NASDAQ) shot up at $1.59, representing a gain of 54.4%. On Mon 02 Dec 19, OTLK:NASDAQ hit a New 2-Week Intraday Low of $0.96. The stock appeared on our News Catalysts scanner on Tue 03 Dec 19 at 08:55 AM in the 'AGREEMENT' category. From Mon 11 Nov 19, the stock recorded 28.57% Up Days and 26.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Outlook Therapeutics, Inc. (OTLK:NASDAQ)

Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.